FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
-2.13%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$270M
AUM Growth
+$270M
Cap. Flow
-$5.11M
Cap. Flow %
-1.89%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
5
Closed
–

Top Buys

1
BDSI
BioDelivery Sciences International, Inc.
BDSI
$2.57M

Top Sells

1
ADAP
Adaptimmune Therapeutics
ADAP
$2.71M
2
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$1.67M
3
AIMT
Aimmune Therapeutics, Inc.
AIMT
$1.53M
4
XLRN
Acceleron Pharma Inc.
XLRN
$1.4M
5
EPZM
Epizyme, Inc
EPZM
$380K

Sector Composition

1 Healthcare 33.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$90.2M 33.37%
1,464,749
– –
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$90M 33.33%
3,300,797
-55,952
-2% -$1.53M
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$26.4M 9.77%
1,586,220
-100,000
-6% -$1.67M
INSM icon
4
Insmed
INSM
$28.8B
$19.6M 7.24%
967,636
– –
EPZM
5
DELISTED
Epizyme, Inc
EPZM
$15.2M 5.62%
1,432,364
-35,851
-2% -$380K
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
$12.6M 4.67%
220,268
-24,488
-10% -$1.4M
ADAP
7
Adaptimmune Therapeutics
ADAP
$15.6M
$6.78M 2.51%
500,000
-200,000
-29% -$2.71M
DNLI icon
8
Denali Therapeutics
DNLI
$2.23B
$5.44M 2.01%
250,000
– –
BDSI
9
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.66M 0.98%
949,233
+918,733
+3,012% +$2.57M
SGMO icon
10
Sangamo Therapeutics
SGMO
$157M
$1.36M 0.5%
80,500
– –